Brief: Biophytis And Skyepharma Sign Partnership For Sarconeos Production
25/09/2023 06:05
Sept 25 (Reuters) - Biophytis SA ALBPS.PA :
* BIOPHYTIS AND SKYEPHARMA SIGN A PARTNERSHIP AGREEMENT FOR
PRODUCTION OF SARCONEOS
* PHARMACEUTICAL DEVELOPMENT WORK AT THE INDUSTRIAL STAGE
WILL
COMPLETE THE INFORMATION REQUIRED FOR EARLY ACCESS
AUTHORIZATIONS, PARTICULARLY IN FRANCE AND BRAZIL
* SKYEPHARMA WILL DEVELOP FINISHED PRODUCT BATCHES MEETING
THE
GMP (GOOD MANUFACTURING PRACTICE) STANDARDS REQUIRED FOR MARKET
ACCESS FILINGS
Source text for Eikon: ID:nNDL92vW1z
Further company coverage: ALBPS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Biophytis SA
See all newsBrief: Biophytis SA Secures $20 Mln For Launch Of Phase 3 Trial In Sarcopenia
Brief: Biophytis Secures Public Funding In Brazil For Obesity Phase 2 Trial
Brief: Biophytis SA Gets EMA Authorization For Phase 2 Clinical Trial In Obesity
Brief: Biophytis Gets EMA & Belgian Regulatory Approval For Phase 3 Sarcopenia Clinical Trial
Brief: Biophytis To Initiate Phase 2 Study In Obesity & Phase 3 Study In Sarcopenia Soon